We highlight the importance of ACE2 genetic polymorphisms, as it may be an effective method to enhance the efficacy of immunotherapeutic and conventional treatments in COVID-19 patients and specifically in obese COVID-19 patients. The gene discussed is ACE2; the disease is COVID-19.